Lenskart adds 203 India stores in H1 FY26 as Titan EyeCare reaches 871
Lenskart is pairing automated eye tests, GeoIQ-led site selection and next-day delivery with local frame production, while Titan EyeCare leans on optometry-led dispensing and omnichannel stores. The contest is increasingly about service speed, store productivity and margin control.
What happened
Lenskart is scaling India through automated eye tests, GeoIQ-led site selection, rapid delivery and local frame manufacturing, while Titan EyeCare relies on
Key facts
- Lenskart NSE listing: Rs 390, 3% below Rs 402 issue price
- Lenskart stock: -2.23% in one month
- Titan stock: +0.99% in one month; +10.85% in one year
- India vision-correction consumers: over 750 million
- India eyewear market: about $9.2 billion / Rs 30,000 crore
- Titan market share: below 12%
- Lenskart eye tests in India H1 FY26: 9.3 million; 46% first-time users
- Lenskart added 203 net new India stores in H1 FY26; presence in 431 cities
- Titan EyeCare exclusive stores: 871 as of September 2025
- Lenskart remote eye testing: over 500 stores
- Lenskart next-day delivery: 58 cities
- Titan delivery cycle: two to three days
- Lenskart Q2 product margin: 69.2%
- Local frame production cost advantage: 35%-40%
- Lenskart frames manufactured in H1: nearly 4 million
Why this matters
The widening Lenskart-Titan contest makes optometry capabilities, diagnostic technology, last-mile delivery and regional manufacturing attractive partnership or acquisition targets for building a differentiated eyewear platform.
What to watch
- Lenskart's same-store sales growth, new-store payback period and EBITDA margin after the H1 FY26 expansion.
- Evidence that next-day delivery expands beyond major metros without materially increasing fulfillment expense.
- Eye-test-to-purchase conversion rates and repeat purchase frequency, especially in newly entered cities.
- Titan EyeCare's exclusive-store growth, average ticket size, premium-lens mix and store-level productivity.
- Promotional intensity, including frame-plus-lens bundles, free eye tests and discounting on private-label versus international brands.
- Optometrist availability, staff attrition and customer satisfaction metrics as both networks scale.
- Any increase in returns, remake rates or prescription-quality complaints tied to automated testing or rapid dispensing.
- Regulatory or quality-control scrutiny of eye-testing practices, prescription dispensing and locally manufactured frames/lenses.
- Lenskart is likely to prioritize cluster expansion in underpenetrated tier-2 and tier-3 cities, using GeoIQ to improve new-store payback rather than simply maximizing footprint.
- Expect more automation in refraction, lens processing and inventory allocation to protect service levels as store count rises.
- Lenskart may use local frame production and private-label assortment to widen price gaps versus branded competitors while preserving gross margin.
- Titan EyeCare is likely to emphasize optometrist-led consultation, premium lenses, insurance/corporate partnerships and omnichannel appointment-to-dispensing journeys.
- Both chains may intensify hiring and retention efforts for optometrists, store managers and technicians, creating wage pressure across organized optical retail.
- Independent opticians may respond through faster local delivery, bundled eye exams and affiliation with online or wholesale platforms.